Zoe Harrison
VP, Accounting and Corporate Development, Dario Health
Replay available
DarioHealth Corp. (NASDAQ: DRIO) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.

VP, Accounting and Corporate Development, Dario Health
Chief Executive Officer, Dario Health
President & Chief Commercial Officer, Dario Health
Chief Financial Officer, Dario Health
Equity Research Analyst, J.D. Cohen & Company
Good morning, ladies and gentlemen, and welcome to the Dario Health First Quarter 2026 Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. This call is being recorded on Wednesday, May 13, 2026. I would now like to turn the conference over to Zoe Harrison, VP Accounting and Corporate Development at Dario Health. Zoe, please go ahead. Thank you, Operator, and good morning, everyone. Thank you for joining us today for a discussion of Dario Health's first quarter 2026 financial results. Leading the call today will be Erez Rafael, Chief Executive Officer of Dario Health. He'll be joined by our President and Chief Commercial Officer, Steven Nelson, and Hen Franco, our Chief Financial Officer. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Wednesday, May 13th, 2026. This morning, we issued a press release announcing our financial results for the first quarter of 2026. The copy of the release can be found on the investor relations page of Dario Health website. I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the federal securities laws. For example, the company is using forward-looking statements when it discusses expected revenue growth and contribution from 2025 signed accounts, its path to profitability and cash flow breakeven, the continued reduction in operating expenses and losses, its expansion of channel partnerships and covered lives reach, its expected revenue and scaling from partner-led and off-cycle opportu...